Nguyen Nam P, Karlsson Ulf, Oboite Eromosele, Alvarenga Julio, Godinez Juan, Zamagni Alice, Motta Micaela, Bose Satya, Vinh-Hung Vincent
Department of Radiation Oncology, Howard University, Washington, DC, USA.
Deapartment of Radiation Oncology, International Geriatric Radiotherapy Group, Washington, DC, USA.
Transl Cancer Res. 2020 Jan;9(Suppl 1):S228-S235. doi: 10.21037/tcr.2019.10.36.
The prevalence of breast cancer increases with age. Older breast cancer patients often present with locally advanced disease at presentation because mammography, which diagnosed early stage disease, is not recommended after the age of 75. In addition, they are often undertreated even when they are physically fit and have non-metastatic disease. As a result, survival is often poor. Physicians bias may be a factor in their undertreatment and lack of representation in prospective clinical trials. Physicians should be educated that chronological age is not a contraindication to curative treatment for older breast cancer patients. As a research group devoted to older cancer patients, women, and minorities, the International Geriatric Radiotherapy Group (IGRG) plans to conduct prospective trials to assess biomarkers for frailty, the controversial issue of mammography for older breast cancer patients, and the incorporation of frailty index for curative breast cancer treatment. The data obtained may help to decrease physician bias and to establish future guidelines for older breast cancer patients treatment.
乳腺癌的患病率随年龄增长而增加。老年乳腺癌患者在就诊时往往表现为局部晚期疾病,因为不建议75岁以上的女性进行用于诊断早期疾病的乳房X光检查。此外,即使他们身体健康且患有非转移性疾病,也常常得不到充分治疗。因此,生存率往往较低。医生的偏见可能是导致他们治疗不足以及在前瞻性临床试验中代表性不足的一个因素。应该让医生明白,实际年龄并非老年乳腺癌患者接受根治性治疗的禁忌证。作为一个致力于老年癌症患者、女性和少数族裔的研究小组,国际老年放射治疗小组(IGRG)计划开展前瞻性试验,以评估虚弱的生物标志物、老年乳腺癌患者乳房X光检查这一有争议的问题,以及将虚弱指数纳入乳腺癌根治性治疗。所获得的数据可能有助于减少医生的偏见,并为老年乳腺癌患者的治疗制定未来的指南。